US$ 20.99
microdosing glp 1 for perimenopause GLP‑1 in Menopause & Understanding GLP-1 Benefits for Perimenopause
Description
This broadened inclusion criteria allowed for a more comprehensive understanding of drug effects in high-risk groups and supported the expansion of GLP-1R agonist indications beyond glycemic control to include cardiovascular and renal benefits
There is also evidence for modulatory effects of GLP-1 RAs on macrophage biology

Table 1 Baseline demography and clinical characteristics of prediabetes versus type 2 diabetes

Lipids GLP-1 RAs generally have a positive yet modest effect on blood lipid profiles

doi: 10.1159/000511130
